At Chiesi, we recognize that the climate crisis is a serious health issue—especially for people living with chronic respiratory conditions. It is now urgent to address climate and health together, and the healthcare industry has a vital role to play.
That’s why we are transitioning our pressurized metered-dose inhalers (pMDIs) to a next-generation propellant, reducing their carbon footprint by up to 90%.
While we innovate behind the scenes, our priority remains unchanged: ensuring patients continue to receive the care they trust—without compromise. Because when it comes to health and sustainability, we’re changing so patients don’t have to.
Click here to learn more about Chiesi’s commitments.
